December 20, 2022 / /
It appears Congress will pass the first major overhaul of cosmetics regulation in 84 years, giving more authority over the market to the FDA. Congressional appropriators filed a 4,155-page, $1.7 trillion omnibus appropriations bill shortly after 1:30 a.m.
The bill includes the Modernization of Cosmetics Regulation Act of 2022, which mirror legislation, S. 4348 (117), the Senate HELP Committee approved in June. This is the first reform to FDA’s regulation of cosmetics in nearly a century. The reforms include:
- adverse event reporting requirements;
- a labeling requirement to include contact information for adverse event reporting;
- ingredient labeling requirement for cosmetic products for professional use (these products are currently exempt from ingredient labeling requirements);
- mandatory recall authority;
- establishment of good manufacturing practices (GMPs) for cosmetics facilities;
- registration and product listing requirements; and
- a requirement for FDA to issue regulations to establish standardized testing methods for detecting and identifying asbestos in talc-containing products.
More details will be posted as they become available.
Posted in FDA News Update, FDA Q&A and tagged with
Are you in trouble with the FDA?
Don’t panic — you’ve got backup. Download 5 Tips to Help You Navigate FDA Enforcement and learn how to resolve the situation right now.